Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/8114
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome |
Author: | Lord, J. Flight, I. Norman, R. |
Citation: | Cochrane Database of Systematic Reviews, 2003; 2003(2):www 1-www 79 |
Publisher: | Update Software Ltd |
Issue Date: | 2003 |
ISSN: | 1469-493X 1464-780X |
Editor: | Tang, T. |
Statement of Responsibility: | J.M. Lord, I.H.K. Flight and R.J. Norman |
Abstract: | Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenaemia and insulin resistance. Hyperinsulinaemia is known to be associated with an increase in cardiovascular risk and the development of diabetes mellitus. If insulin sensitising agents such as metformin are effective in treating features of PCOS, then they could have wider health benefits than just treating the symptoms of the syndrome. |
Keywords: | Humans Polycystic Ovary Syndrome Anovulation Inositol Metformin Thiazoles Thiazolidinediones Chromans Hypoglycemic Agents Ovulation Induction Female Randomized Controlled Trials as Topic Rosiglitazone Pioglitazone Troglitazone |
Description: | Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. |
DOI: | 10.1002/14651858.CD003053 |
Published version: | http://dx.doi.org/10.1002/14651858.cd003053 |
Appears in Collections: | Aurora harvest 4 Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.